Our Program

Bayer has joined forces with world-class academic institutions and other pharma companies as part of the Structural Genomics Consortium (SGC):

 

In an Open Science effort we identify chemical probes for novel drug discovery targets and make them openly available for academic labs who can use these probes without any restrictions to study the disease relevance of such novel targets.

 

This joint effort is for the benefit of patients as high-quality science forms the basis for the next generation of therapeutics. The program is also part of the European IMI project EUbOPEN.

Your order

can be placed through

Our Offer

A set of well-characterized compounds (with corresponding negative probe). Browse the list below!

bcat1-2

Probe Name:
BAY-069

 

Negative Pair:
BAY-771

 

ccr1-ant-0

Probe Name:
BAY-3153

 

Negative Pair:
BAY-173

 

cmet

Probe Name:
BAY-474

 

Negative Pair:
BAY-827

 

 

mmp12-1

Probe Name:
BAY-7598

Negative Pair:
BAY-694

 

 

par1-1

Probe Name:
BAY-386

Negative Pair:
BAY-448

 

trpa1-0

Probe Name:
BAY-390

 

Negative Pair:
BAY-9897

 

Contact
Cora Scholten